Tracking of second primary melanomas in vemurafenib-treated patients.
Dalle S, Poulalhon N, Debarbieux S, Zaharia D, Mihm MC, Lacouture ME, Rosen A, Marghoob AA, Busam KJ, Depaepe L, Bringuier PP, Richez P, Baurain JF, Bressac-de Paillerets B, Balme B, Thomas L.
Dalle S, et al. Among authors: richez p.
JAMA Dermatol. 2013 Apr;149(4):488-90. doi: 10.1001/jamadermatol.2013.21.
JAMA Dermatol. 2013.
PMID: 23715012
No abstract available.